8-K
false0000849146Lifevantage Corp00008491462026-11-062026-11-06

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 06, 2026

 

 

Lifevantage Corporation

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-35647

90-0224471

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

3300 N. Triumph Blvd, Suite 700

 

Lehi, Utah

 

84043

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (801) 432-9000

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, par value $0.0001

 

LFVN

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

LifeVantage Corporation (the “Company”) held its fiscal year 2027 annual meeting of stockholders on November 5, 2026 (the “Annual Meeting”). Of the 12,589,444 shares of the Company’s common stock outstanding as of the record date, 9,421,295 shares, or 74.83% were represented at the Annual Meeting either in person or by proxy. The following proposals were submitted to a vote of the Company’s stockholders at the Annual Meeting:

1. To elect the following six director nominees to the Company’s board of directors to hold office until the next annual meeting of stockholders or until their respective successors are elected and qualified:

Mr. Rajendran Anbalagan

 

Mr. Darwin K. Lewis

Mr. Michael A. Beindorff

 

Mr. Terrence Moorehead

Mr. Raymond B. Greer

 

 

Mr. Dayton Judd

 

 

2. To approve, on an advisory basis, a resolution approving the compensation of the Company’s named executive officers; and

3. To ratify the selection of Deloitte & Touche, LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending June 30, 2027.

The proposals submitted to a vote of the Company’s stockholders at the Annual Meeting are more fully described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission (the “SEC”) on September 18, 2026.

The final voting results of each proposal were as follows:

Proposal 1 – Election of Directors.

 

The Company’s stockholders elected each of the six director nominees listed above to the Company’s board of directors (the “Board”) to serve until the next annual meeting of stockholders or until their respective successors are elected and qualified. Votes cast were as follows:

 

 

 

For

 

Against

 

 

Abstain

Broker Non-Votes

Mr. Rajendran Anbalagan

 

6,886,051

 

160,519

 

 

5,163

2,369,562

Mr. Michael A. Beindorff

 

4,210,997

 

2,827,323

 

 

13,413

2,369,562

 Mr. Raymond B. Greer

 

4,645,713

 

2,401,005

 

 

5,015

2,369,562

Mr. Dayton Judd

 

6,126,017

 

920,733

 

 

4,983

2,369,562

Mr. Darwin K. Lewis

 

4,098,231

 

2,948,519

 

 

4,983

2,369,562

Mr. Terrence Moorehead

 

7,006,287

 

32,321

 

 

13,125

2,369,562

 

Proposal 2 – Approval, on an Advisory Basis, of a Resolution Approving the Compensation of the Company’s Named Executive Officers.

 

The Company’s stockholders approved, on an advisory and non-binding basis, the compensation of the Company’s named executive officers. Votes cast were as follows:

 

For

Against

Abstain

Broker Non-Votes

6,273,776

767,914

10,043

2,369,562

 

 

Proposal 3 – Ratification of Selection of Independent Registered Public Accounting Firm.

 

The Company’s stockholders ratified the selection of Deloitte & Touche, LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2027. Votes cast were as follows:

 

For

 

Against

 

Abstain

9,393,989

 

23,603

 

3,703

 


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

LIFEVANTAGE CORPORATION

 

 

 

 

Date:

November 12, 2026

By:

/s/ Carl A. Aure

 

 

 

Name: Carl A. Aure
Title: Chief Financial Officer